<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht000205.v7" study_id="phs000007.v30" participant_set="11" date_created="Mon Sep 17 10:59:24 2018"><description>Lipid Traits (fractions, particles, size, etc), Offspring Cohort Exams 4, 5</description><variable id="phv00024707.v6"><name>shareid</name><description>UNIQUE PARTICIPANT ID</description></variable><variable id="phv00024681.v6"><name>IDTYPE</name><description>COHORT IDENTIFIER</description><value code="0">ORIGINAL COHORT GROUP</value><value code="1">OFFSPRING GROUP</value><value code="3">GENERATION 3</value></variable><variable id="phv00024682.v6"><name>CHYLO</name><description>CHYLOMICRON PARTICLES SIZE &gt; 220 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024683.v6"><name>VLDLP6</name><description>VLDL PARTICLES SIZE 150+/-70 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024684.v6"><name>VLDLP5</name><description>VLDL PARTICLES SIZE 70+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024685.v6"><name>VLDLP4</name><description>VLDL PARTICLES SIZE 50+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024686.v6"><name>VLDLP3</name><description>VLDL PARTICLES SIZE 38+/-3 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024687.v6"><name>VLDLP2</name><description>VLDL PARTICLES SIZE 33+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024688.v6"><name>VLDLP1</name><description>VLDL PARTICLES SIZE 29+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024689.v6"><name>IDLP</name><description>IDL PARTICLES 25+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024690.v6"><name>LDLP3</name><description>LDL PARTICLES 22+/-0.7 NM
 (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024691.v6"><name>LDLP2</name><description>LDL PARTICLES 20.5+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024692.v6"><name>LDLP1</name><description>LDL PARTICLES 19+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024693.v6"><name>HDLP5</name><description>HDL PARTICLES 11.5+/-1.5 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024694.v6"><name>HDLP4</name><description>HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024695.v6"><name>HDLP3</name><description>HDL PARTICLES 8.5+/-0.3 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024696.v6"><name>HDLP2</name><description>HDL PARTICLES 8.0+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024697.v6"><name>HDLP1</name><description>HDL PARTICLES 7.5+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024698.v6"><name>VLDLSZ</name><description>WEIGHTED AVERAGE FOR VLDL SIZE BASED ON MEASUREMENTS OF VLDLP1 THROUGH VLDLP6, EXAM 4</description></variable><variable id="phv00024699.v6"><name>LDLSZ</name><description>WEIGHTED AVERAGE FOR LDL SIZE BASED ON MEASUREMENTS OF LDLP1 THROUGH LDLP6, EXAM 4</description></variable><variable id="phv00024700.v6"><name>HDLSZ</name><description>WEIGHTED AVERAGE FOR HDL SIZE BASED ON MEASUREMENTS OF HDLP1 THROUGH HDLP6, EXAM 4</description></variable><variable id="phv00024701.v6"><name>APOCIIIT</name><description>APOLIPOPROTEIN CIII CONCENTRATION DETERMINED USING NEPHELOMETRIC ASSAY FROM WACO (MG/DL), EXAM 5</description><unit>MG/DL</unit></variable><variable id="phv00024702.v6"><name>APOA14</name><description>APOLIPOPROTEIN AI CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024703.v6"><name>APOB4</name><description>APOLIPOPPROTEIN B CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024704.v6"><name>RLP_C</name><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS CHOLESTEROL IN MG/DL, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024705.v6"><name>RLP_TG</name><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS TRIGLYCERIDES IN MG/DL, EXAM 4</description><unit>MG/DL</unit></variable><variable id="phv00024706.v6"><name>APOESER5</name><description>APOE CONCENTRATIONS IN MG/DL USING IMMUNOCHEMICAL TECHNIQUE BY SERVIA, EXAM 5</description><unit>MG/DL</unit></variable></data_table>
